<?xml version="1.0" encoding="UTF-8"?>
<ref id="B174">
 <label>174</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lopez Vicchi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Luque</surname>
    <given-names>G. M.</given-names>
   </name>
   <name>
    <surname>Brie</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Nogueira</surname>
    <given-names>J. P.</given-names>
   </name>
   <name>
    <surname>Garcia Tornadu</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Becu-Villalobos</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Dopaminergic drugs in type 2 diabetes and glucose homeostasis</article-title>
  <source>
   <italic toggle="yes">Pharmacological Research</italic>
  </source>
  <year>2016</year>
  <volume>109</volume>
  <fpage>74</fpage>
  <lpage>80</lpage>
  <pub-id pub-id-type="doi">10.1016/j.phrs.2015.12.029</pub-id>
  <pub-id pub-id-type="other">2-s2.0-84953439344</pub-id>
  <pub-id pub-id-type="pmid">26748034</pub-id>
 </element-citation>
</ref>
